Veysel Sabri Hançer

527 total citations
47 papers, 378 citations indexed

About

Veysel Sabri Hançer is a scholar working on Hematology, Molecular Biology and Rheumatology. According to data from OpenAlex, Veysel Sabri Hançer has authored 47 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 11 papers in Molecular Biology and 10 papers in Rheumatology. Recurrent topics in Veysel Sabri Hançer's work include Platelet Disorders and Treatments (9 papers), Systemic Lupus Erythematosus Research (7 papers) and Cell Adhesion Molecules Research (7 papers). Veysel Sabri Hançer is often cited by papers focused on Platelet Disorders and Treatments (9 papers), Systemic Lupus Erythematosus Research (7 papers) and Cell Adhesion Molecules Research (7 papers). Veysel Sabri Hançer collaborates with scholars based in Türkiye, United Kingdom and United States. Veysel Sabri Hançer's co-authors include Reyhan Diz Küçükkaya, Meliha Nalçacı, Umut Selda Bayrakçı, Oğuz Söylemezoğlu, Esra Baskın, Kaan Gülleroğlu, Beste Özben, Kibriya Fidan, Murat İnanç and Aytaç Öncül and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Veysel Sabri Hançer

40 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Veysel Sabri Hançer Türkiye 11 125 121 81 70 66 47 378
Abdullah Hacıhanefioğlu Türkiye 11 222 1.8× 52 0.4× 36 0.4× 106 1.5× 124 1.9× 30 424
Koji Suzuki Japan 9 186 1.5× 77 0.6× 30 0.4× 55 0.8× 39 0.6× 11 343
Malcolm A. Cunningham Australia 7 272 2.2× 134 1.1× 100 1.2× 63 0.9× 45 0.7× 8 514
Cécile Contin France 4 151 1.2× 140 1.2× 21 0.3× 30 0.4× 48 0.7× 6 371
Miao Qi Australia 11 116 0.9× 109 0.9× 22 0.3× 159 2.3× 106 1.6× 27 452
Eitan Giat Israel 7 45 0.4× 178 1.5× 45 0.6× 82 1.2× 210 3.2× 14 487
Eva Kabrna Austria 10 321 2.6× 150 1.2× 41 0.5× 46 0.7× 67 1.0× 13 508
Keiko Hamai Japan 11 56 0.4× 57 0.5× 165 2.0× 98 1.4× 115 1.7× 15 367
Xiaozhou Hu China 12 21 0.2× 207 1.7× 70 0.9× 57 0.8× 127 1.9× 33 593
Willeke E.M. Schroeijers Netherlands 13 77 0.6× 262 2.2× 149 1.8× 37 0.5× 65 1.0× 15 409

Countries citing papers authored by Veysel Sabri Hançer

Since Specialization
Citations

This map shows the geographic impact of Veysel Sabri Hançer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veysel Sabri Hançer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veysel Sabri Hançer more than expected).

Fields of papers citing papers by Veysel Sabri Hançer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Veysel Sabri Hançer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veysel Sabri Hançer. The network helps show where Veysel Sabri Hançer may publish in the future.

Co-authorship network of co-authors of Veysel Sabri Hançer

This figure shows the co-authorship network connecting the top 25 collaborators of Veysel Sabri Hançer. A scholar is included among the top collaborators of Veysel Sabri Hançer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Veysel Sabri Hançer. Veysel Sabri Hançer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sayitoğlu, Müge, et al.. (2023). NOVEL RUNX1 VARIATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases. 15(1). e2023036–e2023036.
2.
Hançer, Veysel Sabri, et al.. (2023). The First Congenital Disorders of Glycosylation Patient (Fetus) with Homozygous COG5 c.95T>G Variant. Molecular Syndromology. 14(2). 181–184. 1 indexed citations
3.
Erdem, Simge, Veysel Sabri Hançer, Meliha Nalçacı, et al.. (2021). A case mimicking chronic myeloid leukemia with t(8;22)(p11;q11)/BCR-FGFR1 and sequential transformation to B-acute lymphoblastic leukemia and acute myeloid leukemia. Journal of Hematopathology. 14(2). 151–156.
4.
Hançer, Veysel Sabri, et al.. (2020). A Novel <b><i>COL3A1 </i></b>c.2644G>T; p.(Gly882Cys) Variant in a Turkish Family with Vascular Ehlers-Danlos Syndrome. Molecular Syndromology. 11(2). 110–114. 1 indexed citations
5.
Küçükkaya, Reyhan Diz, et al.. (2019). A Novel ATP6V0A2 Mutation Causing Recessive Cutis Laxa with Unusual Manifestations of Bleeding Diathesis and Defective Wound Healing. Turkish Journal of Hematology. 36(1). 29–36. 9 indexed citations
6.
Kahraman, Resul, Veysel Sabri Hançer, Arzu Ergen, Bedia Çakmakoğlu, & Reyhan Diz Küçükkaya. (2019). Evaluation of Tissue Factor -603 A/G Promoter Gene Polymorphism in Thrombotic Processes in Patients with Antiphospholipid Syndrome. 9(1). 1–6. 1 indexed citations
7.
Hançer, Veysel Sabri, et al.. (2019). A Novel Pathological ARSB Mutation (c.870G>A; p.Trp290stop) in Mucopolysaccharidosis Type VI Patients. Molecular Syndromology. 10(5). 272–275. 3 indexed citations
8.
Sağlam, Sezer, Esra Sağlam, Pınar Fırat, et al.. (2018). Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment. Pathology - Research and Practice. 214(9). 1291–1296. 1 indexed citations
9.
Hançer, Veysel Sabri, et al.. (2018). β Globin Mutations in Turkish, Northern Iraqi and Albanian Patients with β Thalassemia Major. SHILAP Revista de lepidopterología. 8(2). 7286–7286. 1 indexed citations
10.
Yiğiter, Alin Başgül, et al.. (2015). Non-invasive prenatal diagnosis of fetal RhD by using free fetal DNA. Clinical and Experimental Obstetrics & Gynecology. 42(3). 344–346. 3 indexed citations
11.
Ekinci, Zelal, et al.. (2014). Renal outcome with eculizumab in two diarrhea-associated hemolytic–uremic syndrome cases with severe neurologic involvement. Hong Kong Journal of Nephrology. 16(2). 46–49. 9 indexed citations
12.
Hançer, Veysel Sabri, et al.. (2014). The impact of prothrombotic mutations, PSGL-1 VNTR polymorphism, tissue factor, and soluble P-selectin on venous thromboembolism in cancer patients with adenocarcinoma.. Journal of Clinical Oncology. 32(15_suppl). e22049–e22049. 1 indexed citations
13.
Hançer, Veysel Sabri, et al.. (2014). The Relationship between P-Selectin Polymorphisms and Thrombosis in Antiphospholipid Syndrome: A Pilot Case-Control Study. Turkish Journal of Hematology. 31(4). 357–362. 10 indexed citations
14.
Demirelli, Selami, et al.. (2013). Investigation of Arrhythmia Markers and KCNJ8-S422L Gene Mutation in a Population with Early Repolarization Pattern on ECG. Journal of the American College of Cardiology. 62(18). C68–C68.
15.
Akpınar, Timur Selçuk, Veysel Sabri Hançer, Meliha Nalçacı, & Reyhan Diz Küçükkaya. (2013). MPL W515L/K Mutations in Chronic Myeloproliferative Neoplasms. SHILAP Revista de lepidopterología. 30(1). 8–12. 20 indexed citations
16.
Pınarbaşı, Binnur, Fehmi Hindilerden, Veysel Sabri Hançer, et al.. (2012). The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis. Journal of Thrombosis and Thrombolysis. 34(3). 388–396. 18 indexed citations
17.
Hançer, Veysel Sabri, et al.. (2011). Comparison of KRAS Mutation Tests in Colorectal Cancer Patients. Genetic Testing and Molecular Biomarkers. 15(11). 831–834. 10 indexed citations
18.
Hançer, Veysel Sabri, et al.. (2011). ADAMTS-13 gene expression in antiphospholipid syndrome. SHILAP Revista de lepidopterología. 28(3). 213–218. 3 indexed citations
19.
Hançer, Veysel Sabri, et al.. (2010). Cytotoxic T lymphocyte antigen-4 (CTLA-4) A49G polymorphism and autoimmune blood diseases. Turkish Journal of Hematology. 27(2). 78–81. 5 indexed citations
20.
Özben, Beste, Reyhan Diz Küçükkaya, Ahmet Kaya Bilge, Veysel Sabri Hançer, & Aytaç Öncül. (2007). The association of P-selectin glycoprotein ligand-1 VNTR polymorphisms with coronary stent restenosis. Journal of Thrombosis and Thrombolysis. 23(3). 181–187. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdullah Hacıhanefioğlu Breakdown of academic impact, for papers by Koji Suzuki Breakdown of academic impact, for papers by Malcolm A. Cunningham Breakdown of academic impact, for papers by Cécile Contin Breakdown of academic impact, for papers by Miao Qi Breakdown of academic impact, for papers by Eitan Giat Breakdown of academic impact, for papers by Eva Kabrna Breakdown of academic impact, for papers by Keiko Hamai Breakdown of academic impact, for papers by Xiaozhou Hu Breakdown of academic impact, for papers by Willeke E.M. Schroeijers
Rankless by CCL
2026